
Organon Investor Relations Material
Latest events

Q2 2025
Organon
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Organon & Co
Access all reports
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. The company operates under the Organon & Co. Pharmaceuticals and Organon brands. Its products include hormone contraceptives; biosimilars; women's health products consisting of fertility, menopause, contraception, osteoporosis and gynecological cancer; and treatments for psychiatric and neurological disorders comprising schizophrenia, bipolar mania disorder and depression. The company also offers food animal health products, including pain relief for horses, cattle and sheep; and anti-infectives for poultry.
Key slides for Organon & Co


Q4 2024
Organon & Co


Q3 2024
Organon & Co
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
OGN
Country
🇺🇸 United States